New Parkinson's drug candidate enters early human testing
NCT ID NCT07422675
First seen Feb 21, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This early-stage study tests a single dose of SER-252 in 40 people with Parkinson's disease who experience motor fluctuations (uncontrolled movements). The main goal is to check the drug's safety and how the body processes it. Participants receive either SER-252 or a placebo, and researchers monitor side effects and drug levels over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
K2 Medical Research LLC
RECRUITINGMaitland, Florida, 32751, United States
Contact
-
Monash
RECRUITINGMelbourne, Victoria, 3170, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Quest Research Institute
RECRUITINGFarmington Hills, Michigan, 28555, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rocky Mountain Clinical Research
NOT_YET_RECRUITINGEnglewood, Colorado, 80113, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Velocity Clinical Research
NOT_YET_RECRUITINGHallandale, Florida, 33009, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.